Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells
about
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionMultiple molecular targets of resveratrol: Anti-carcinogenic mechanismsGelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasTrophoblast 'pseudo-tumorigenesis': significance and contributory factorsExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesEffectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cellsActivation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasionPhysiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lungRole of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancerProteinase requirements of epidermal growth factor-induced ovarian cancer cell invasionThe levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activationArsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant responseOverabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenicThe enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphomaThe plasmin cascade and matrix metalloproteinases in non-small cell lung cancerMatrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancerPhysiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expressionKiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter.All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory moleculesComplex roles of tissue inhibitors of metalloproteinases in cancer.Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma.HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis.Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domainsmiR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancerFunctional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells.Induction of human squamous cell-type carcinomas by arsenic.Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinomaMatrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasionRegulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancerComparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
P2860
Q24322566-4314899A-F376-4B04-A4ED-4EE1A1E1D695Q24568374-29E5ACD3-BD6E-4AE3-886D-F9FA7BD9C55CQ24648759-C74D5E9C-BBB1-40C9-B87B-0768B792B039Q24649857-B164B69F-5C32-474B-881C-3CD3EFB777E1Q24798593-067129EB-856B-4BAE-986C-64BF74088319Q27021694-415C011D-01E5-4195-A184-9F55AD5189AFQ27335252-B1652C38-9DE2-4BF9-86EA-6A2BFB5A3728Q28142815-4D0BF49F-4440-4531-BD65-D82688578E63Q28261578-A800419D-D732-4805-9E14-CF00A9FEC2A3Q28269683-FE60DD39-FD86-4487-A841-809AD8D2F83AQ28273513-B7B75ACD-B75D-4E61-B52E-2DBDC1E5F08EQ28284948-62EDABE8-0C26-4B94-B529-C724E10D2034Q28365272-3409794D-0165-490E-B76F-DC1DC0E94EA9Q28387886-5BFF6C79-3977-4E0C-8A5B-9DB5DFAACDC0Q28391764-28A2CC69-6B48-4034-8BEA-FDA700D5268BQ28394988-EC2399D6-B415-4744-A32A-5676C4E32FD2Q33311418-C7D893DF-FC28-4083-92B4-093D8DECCC58Q33634208-B4E1AC4C-F24B-414E-90FC-A3A40A17F7E6Q33652022-327102D1-C28B-4B89-A5F2-E3820C67F741Q33760250-5C83C1F0-EADC-49C7-9464-69D00F018E04Q33815241-678DE8E5-D5B5-47D1-978B-7EED2C4D3A7FQ33886514-394D7440-4E5C-4AE5-AE1F-FEAD464F242FQ33918409-81F6757F-A634-4748-8DDA-4B48934B6C4BQ33923957-6A040FC4-44DD-4FC3-8EFB-5F563C6BCFDFQ34109489-D04A958A-8E6D-402D-9CFE-842205BD3E21Q34219471-7A859F7A-E45E-4C10-96F0-72383B473896Q34596110-449211D9-DA87-4EE6-B798-A41ABF9853EDQ34755399-30131B9C-50CB-47CF-9BF1-0B5E6137B040Q34885424-050524DF-84C2-4996-85B4-3EA090A5883BQ35068692-857C8C8F-56AA-4D05-A5DF-52FF329ED0D6Q35095838-83745F55-7F4E-4A51-86B8-6C2A4C3D1A60Q35144029-AFB72BF2-1966-42BA-8248-F978D0432FCAQ35376245-80250EB0-D3B7-4A17-8526-80A9B7D7664EQ35607441-90CBDDCB-73C2-41DB-9F00-B10AFD3581FCQ35763791-A8CC728C-B341-438B-A4C4-FEBE4C87CB39Q35774094-07578AC1-44D3-4771-B78E-90452A19F1B5Q35911136-F4744186-0486-4CAE-BF09-D004D5765C40Q36006767-4082DD3E-E556-465F-89E0-DE836D28AEC1Q36115177-9F729E6D-C1A4-4BA2-A55A-7CC2350F059DQ36135135-5B4F634E-CC6D-4586-B7AD-950AEFC95D44
P2860
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Direct evidence linking expres ...... n transformed rat embryo cells
@ast
Direct evidence linking expres ...... n transformed rat embryo cells
@en
type
label
Direct evidence linking expres ...... n transformed rat embryo cells
@ast
Direct evidence linking expres ...... n transformed rat embryo cells
@en
prefLabel
Direct evidence linking expres ...... n transformed rat embryo cells
@ast
Direct evidence linking expres ...... n transformed rat embryo cells
@en
P2093
P2860
P356
P1476
Direct evidence linking expres ...... n transformed rat embryo cells
@en
P2093
E J Bernhard
R J Muschel
S B Gruber
P2860
P304
P356
10.1073/PNAS.91.10.4293
P407
P577
1994-05-01T00:00:00Z